{"transactions":[{"id":914758,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-09T21:25:19.000Z","date":"2026-02-06","kind":"purchase","planned":false,"acquired":true,"shares":300,"price":2.7,"value":810.0,"ownership":{"direct":true},"balance_after":65682,"source":{"system":"sec-edgar","filing":"0001133416-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341626000048/form4.xml","form_type":"4"}},{"id":934507,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-01-21T21:49:04.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on December 31, 2026."}],"balance_after":60000,"derivative":{"exercise_price":3.04,"expiration_date":"2036-01-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001133416-26-000034","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341626000034/form4.xml","form_type":"4"}},{"id":959969,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-23T18:17:21.000Z","date":"2025-12-23","kind":"purchase","planned":false,"acquired":true,"shares":700,"price":3.73,"value":2611.0,"ownership":{"direct":true},"balance_after":65382,"source":{"system":"sec-edgar","filing":"0001133416-25-000078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341625000078/form4.xml","form_type":"4"}},{"id":959967,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-23T16:28:55.000Z","date":"2025-12-23","kind":"purchase","planned":true,"acquired":true,"shares":700,"price":3.73,"value":2611.0,"ownership":{"direct":true},"balance_after":65382,"source":{"system":"sec-edgar","filing":"0001133416-25-000074","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341625000074/form4.xml","form_type":"4"}},{"id":1083578,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-22T11:36:26.000Z","date":"2025-07-21","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.925,"value":2925.0,"ownership":{"direct":true},"balance_after":64682,"source":{"system":"sec-edgar","filing":"0001133416-25-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341625000035/form4.xml","form_type":"4"}},{"id":1294681,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-01-27T21:03:53.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on December 31, 2025."}],"balance_after":60000,"derivative":{"exercise_price":1.23,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001133416-25-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341625000008/form4.xml","form_type":"4"}},{"id":1322062,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-12-26T13:07:55.000Z","date":"2024-12-24","kind":"purchase","planned":false,"acquired":true,"shares":13469,"price":0.82,"value":11044.58,"ownership":{"direct":true},"balance_after":63682,"source":{"system":"sec-edgar","filing":"0001133416-24-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341624000064/form4.xml","form_type":"4"}},{"id":1382516,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-10-23T17:39:39.000Z","date":"2024-10-23","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":2.6,"value":1300.0,"ownership":{"direct":true},"balance_after":50213,"source":{"system":"sec-edgar","filing":"0001133416-24-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341624000060/form4.xml","form_type":"4"}},{"id":1450070,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-23T13:43:32.000Z","date":"2024-07-22","kind":"purchase","planned":false,"acquired":true,"shares":400,"price":2.39,"value":956.0,"ownership":{"direct":true},"balance_after":49713,"source":{"system":"sec-edgar","filing":"0001133416-24-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341624000048/form4.xml","form_type":"4/A","original_submission_date":"2024-07-23"}},{"id":1450069,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-23T13:38:41.000Z","date":"2024-01-16","kind":"purchase","planned":false,"acquired":true,"shares":400,"price":2.39,"value":956.0,"ownership":{"direct":true},"balance_after":49713,"source":{"system":"sec-edgar","filing":"0001133416-24-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341624000046/form4.xml","form_type":"4"}},{"id":1655581,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-02-07T21:46:30.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on December 31, 2024."}],"balance_after":50000,"derivative":{"exercise_price":1.72,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001133416-24-000014","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341624000014/form4.xml","form_type":"4"}},{"id":1679254,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-16T16:23:48.000Z","date":"2024-01-16","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":1.7858,"value":892.9,"ownership":{"direct":true},"balance_after":49313,"source":{"system":"sec-edgar","filing":"0001133416-24-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341624000004/form4.xml","form_type":"4"}},{"id":1825987,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-20T11:40:23.000Z","date":"2023-07-19","kind":"purchase","planned":false,"acquired":true,"shares":1598,"price":1.786,"value":2854.028,"ownership":{"direct":true},"balance_after":48813,"source":{"system":"sec-edgar","filing":"0001133416-23-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341623000065/form4.xml","form_type":"4"}},{"id":2004109,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-21T17:16:38.000Z","date":"2023-02-21","kind":"purchase","acquired":true,"shares":1000,"price":1.5911,"value":1591.1,"ownership":{"direct":true},"balance_after":47215,"source":{"system":"sec-edgar","filing":"0001133416-23-000043","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341623000043/form4.xml","form_type":"4"}},{"id":2042454,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-01-30T21:40:43.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on December 31, 2023."}],"balance_after":40000,"derivative":{"exercise_price":1.11,"expiration_date":"2033-01-26","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001133416-23-000020","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341623000020/form4.xml","form_type":"4"}},{"id":2045293,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-26T12:44:04.000Z","date":"2023-01-25","kind":"purchase","acquired":true,"shares":1300,"price":1.11,"value":1443.0,"ownership":{"direct":true},"balance_after":46215,"source":{"system":"sec-edgar","filing":"0001133416-23-000006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341623000006/form4.xml","form_type":"4"}},{"id":2426937,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-01-25T21:49:11.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on December 31, 2022."}],"balance_after":40000,"derivative":{"exercise_price":1.98,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001133416-22-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000113341622000035/form4.xml","form_type":"4"}},{"id":2769583,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-03-29T20:35:09.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Such options vest when (i) the Company has received the interim results of its NAVIGATE clinical trial and (ii) makes a public announcement that it has received the interim results."}],"balance_after":70000,"derivative":{"exercise_price":2.11,"expiration_date":"2031-03-25","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000899243-21-013809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000089924321013809/doc4.xml","form_type":"4"}},{"id":2769582,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-03-29T20:35:09.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Such options vest 100% on March 31, 2022."}],"balance_after":40000,"derivative":{"exercise_price":2.11,"expiration_date":"2031-03-25","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-21-013809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000089924321013809/doc4.xml","form_type":"4"}},{"id":3312692,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-01-13T23:05:29.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on December 31, 2020."}],"balance_after":30000,"derivative":{"exercise_price":2.86,"expiration_date":"2030-01-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-20-001127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000089924320001127/doc4.xml","form_type":"4"}},{"id":3505072,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant (right to buy)","published_at":"2019-06-03T21:42:19.000Z","date":"2019-05-31","kind":"purchase","acquired":true,"shares":10110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Each warrant is exerciseable for 0.075 shares of Common Stock of the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Each warrant is exerciseable for 0.075 shares of Common Stock of the Company."}],"balance_after":10110,"derivative":{"exercise_price":7,"exercise_date":"2019-11-30","expiration_date":"2026-05-31","underlying":"Common stock","underlying_shares":758},"source":{"system":"sec-edgar","filing":"0001179022-19-000036","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000117902219000036/edgar.xml","form_type":"4"}},{"id":3505071,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-03T21:42:19.000Z","date":"2019-05-31","kind":"purchase","acquired":true,"shares":3033,"price":4.28,"value":12981.24,"ownership":{"direct":true},"balance_after":44415,"source":{"system":"sec-edgar","filing":"0001179022-19-000036","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000117902219000036/edgar.xml","form_type":"4"}},{"id":3691961,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-01-18T22:20:01.000Z","date":"2019-01-16","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on January 16, 2020."}],"balance_after":25000,"derivative":{"exercise_price":4.72,"expiration_date":"2029-01-16","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179022-19-000017","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000117902219000017/edgar.xml","form_type":"4"}},{"id":3807643,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-26T11:59:25.000Z","date":"2018-09-25","kind":"purchase","acquired":true,"shares":2000,"price":6.0999,"value":12199.8,"ownership":{"direct":true},"balance_after":41382,"source":{"system":"sec-edgar","filing":"0001179022-18-000072","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000117902218000072/edgar.xml","form_type":"4"}},{"id":3915764,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":67287,"kind":"person","name":"ELDRED KARY","position":1,"cik":"0001543425","reported_name":"ELDRED KARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-05-29T20:30:58.000Z","date":"2018-05-22","kind":"grant","acquired":true,"shares":46875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on May 22, 2019."}],"balance_after":46875,"derivative":{"exercise_price":4.16,"expiration_date":"2028-05-22","underlying":"Common stock","underlying_shares":46875},"source":{"system":"sec-edgar","filing":"0001179022-18-000043","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000117902218000043/edgar.xml","form_type":"4"}}]}